SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-06-11 12:45
Tx date 2026-06-10 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$174,000
+20,000 vol
$8.70 each 		232,229
Filed 2026-05-11 17:07
Tx date 2026-05-11 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-58,839.30
-8,346 vol
$7.05 each 		61,314
Filed 2026-05-11 17:06
Tx date 2026-05-11 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$34,999
+14,344 vol
$2.44 each 		69,660
Filed 2026-05-11 17:06
Tx date 2026-05-11 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-34,999.36
-14,344 vol
$2.44 each 		212,229
Filed 2025-10-10 13:22
Tx date 2025-10-10 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-16,401
-1,775 vol
$9.24 each 		55,316
Filed 2025-10-10 13:21
Tx date 2025-10-10 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,996
+4,062 vol
$1.23 each 		57,091
Filed 2025-10-10 13:20
Tx date 2025-10-10 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-4,996.26
-4,062 vol
$1.23 each 		226,573
Filed 2025-07-08 09:09
Tx date 2025-07-07 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,746.49
-1,119 vol
$8.71 each 		53,029
Filed 2025-07-08 09:08
Tx date 2025-07-07 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,998
+2,127 vol
$2.35 each 		54,148
Filed 2025-07-08 09:06
Tx date 2025-07-07 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-4,998.45
-2,127 vol
$2.35 each 		230,635
Filed 2025-06-05 12:43
Tx date 2025-06-03 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$157,600
+20,000 vol
$7.88 each 		232,762
Filed 2025-04-11 16:09
Tx date 2025-04-11 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-6,974.55
-1,409 vol
$4.95 each 		52,021
Filed 2025-04-11 16:08
Tx date 2025-04-11 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,997
+2,173 vol
$2.30 each 		53,430
Filed 2025-04-11 16:07
Tx date 2025-04-11 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-4,997.90
-2,173 vol
$2.30 each 		212,762
Filed 2025-02-14 17:00
Tx date 2025-02-14 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-8,088.52
-1,186 vol
$6.82 each 		51,257
Filed 2025-02-14 17:00
Tx date 2025-02-14 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$499,992
+1,992 vol
$251.00 each 		52,443
Filed 2025-02-14 16:59
Tx date 2025-02-14 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-4,999.92
-1,992 vol
$2.51 each 		214,935
Filed 2024-10-08 17:15
Tx date 2024-10-08 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-6,369.18
-1,406 vol
$4.53 each 		50,451
Filed 2024-10-08 17:15
Tx date 2024-10-08 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,998
+1,960 vol
$2.55 each 		51,857
Filed 2024-10-08 17:13
Tx date 2024-10-08 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-4,998
-1,960 vol
$2.55 each 		216,927